Circulating glucose, insulin and ketone bodies and enzymes of ketone body utilization in brain mitochondria from suckling rats treated with high L-thyroxine doses.
The neo-T4 syndrome was induced by subcutaneous administration of a total dose of (150 micrograms) L-thyroxine (T4) to rats from their first day of live. Neo-T4 animals and their controls were sacrificed at 2, 4, 8, 11, 14, 22 and 25 days of age. A decrease in body weight was observed from the second day of life, and a decrease in brain weight from the eighth day of life in the neo-T4 animals. Blood glucose and plasma insulin levels were decreased from 2nd day through 22nd day of life. Total plasma ketone bodies and beta-OH butyrate levels increased in the neo-T4 animals with respect to controls. until 8th day, although acetoacetate increased only until 4th day. The activity of key enzymes in the ketone bodies utilization pathway (3-hydroxybutyrate dehydrogenase, 3-oxoacid CoA-transferase and acetoacetyl-CoA thiolase) were also measured in the animals brain. We found an activation of 3-hydroxybutyrate dehydrogenase until 11th day and 3-oxoacid CoA-transferase until 14th day, but no change in acetoacetyl CoA-thiolase was observed. Ketone bodies play a key role as energy substrates and precursors of brain lipids during the period of intense growth and myelination of the CNS. Considering the alterations described in this paper it seems that neo-T4 syndrome could be an interesting model for studying metabolism of those substances in brain.
D000101:Acetyl-CoA C-Acetyltransferase / Q000032:analysis; D000818:Animals; D000833:Animals, Suckling; D001786:Blood Glucose / Q000032:analysis*; D001835:Body Weight / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D015256:Coenzyme A-Transferases; D006884:Hydroxybutyrate Dehydrogenase / Q000032:analysis; D007328:Insulin / Q000097:blood*; D007657:Ketone Bodies / Q000097:blood*; D008928:Mitochondria / Q000201:enzymology*; D051381:Rats; D011919:Rats, Inbred Strains; D013466:Sulfurtransferases / Q000032:analysis; D013974:Thyroxine / Q000494:pharmacology*
D001786:Blood Glucose; D007328:Insulin; D007657:Ketone Bodies; D006884:Hydroxybutyrate Dehydrogenase; D000101:Acetyl-CoA C-Acetyltransferase; D013466:Sulfurtransferases; D015256:Coenzyme A-Transferases; C021460:3-ketoacid CoA-transferase; D013974:Thyroxine